Executive readout · one minute
Webcast research workspace
Read the call alongside every captured source. 8-K earnings release, 8-K call announcement, 10-Q stay in one workspace.
INBX
$96.31
+1.06%
INBX
· Inhibrx Biosciences, Inc.
$96.31
+1.01 (+1.06%)
At close · Oct 21
Return incl. dividend (before tax)
Market Cap
$1.40B
Shares
14.72M
Volume · Oct 20
221.46K
Avg daily vol (3M)
274.07K
All webcasts
Earnings call · FY2026 Q2
Inhibrx Biosciences, Inc. (INBX) Q2 2026 Earnings Call
Revenue
$0
-100% YoY
Diluted EPS
-$2.34
Net income
-$36.65M
Research coverage
3 live sources
Open each available source without leaving this research workspace.
Research materials
Open the source you need; every reader stays inside this workspace.
Quarter detail
How the reported period landed and where the business moved.
SEC filing · Item 2.02
8-K earnings release
Filed Aug 13, 2026 · complete as-filed document
SEC periodic report
10-Q report
Filed Aug 13, 2026 · complete as-filed document
SEC call announcement
8-K call announcement
Filed Sep 8, 2026 · complete as-filed document